Status:
RECRUITING
Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Coexistence of Cerebral and Coronary Atherosclerosis
Acute Ischemic Cerebrovascular Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry (CoCCA) is a single-center observational registry of patients hospitalized for acute is...
Detailed Description
Atherosclerosis has exerted huge global burden as the common pathological process underlying ischemic heart disease and cerebrovascular disease. A substantial portion of acute ischemic cerebrovascular...
Eligibility Criteria
Inclusion
- Diagnosed as ischemic stroke or transient ischemic attack (TIA).
- Less than 30 days after onset of ischemic stroke or TIA symptoms.
- Extracranial or intracranial cerebral atherosclerosis confirmed by vascular ultrasound or CT angiograpgy or MR angiograpgy or digital substraction angiography.
- Coronary atherosclerosis confirmed by CT angiograpgy or MR angiograpgy or digital substraction angiography; or with myocardial ischemia symptoms confirmed using electrocardiogram or echocardiography or cardiac MR; or with a history of percutaneous coronary intervention or coronary artery bypass graft.
Exclusion
- With malignant tumors or poor organ functions or hematologic diseases, whose estimated life expectancy is less than 5 years.
- Patients refuse to participate in the research.
Key Trial Info
Start Date :
January 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03788512
Start Date
January 12 2019
End Date
December 1 2027
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, BJ, China, 100053